JMP Securities lowered shares of Notable Labs (NASDAQ:NTBL – Free Report) from an outperform rating to a market perform rating in a report issued on Friday morning, MarketBeat reports.
Notable Labs Stock Down 6.0 %
Shares of NTBL stock opened at $0.45 on Friday. Notable Labs has a 52-week low of $0.40 and a 52-week high of $10.08. The company has a quick ratio of 2.77, a current ratio of 2.77 and a debt-to-equity ratio of 0.03. The firm’s 50-day moving average is $0.56 and its 200-day moving average is $0.90.
Notable Labs (NASDAQ:NTBL – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.55) earnings per share (EPS) for the quarter. As a group, equities research analysts forecast that Notable Labs will post -0.75 EPS for the current fiscal year.
Notable Labs Company Profile
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.
See Also
- Five stocks we like better than Notable Labs
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Investing in Commodities: What Are They? How to Invest in Them
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with MarketBeat.com's FREE daily email newsletter.
